Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel chemokine identified and characterized at Millennium

Jan. 30, 1998

Lilly patents new voltage-sensitive calcium channel antagonists for CNS disorders

Jan. 30, 1998

Novel class of muscarinic receptor agonists described by Pfizer

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

Potent, orally active inhibitor of kynurenine 3-hydroxylase discovered at Roche

Jan. 29, 1998

Tsumura team reveals semisynthetic huperzine derivatives

Jan. 29, 1998

New excitatory amino acid antagonists in development at Pfizer

Jan. 29, 1998

Phase II trials of Sibia's Parkinson's disease Rx begin

Jan. 28, 1998

EUK-134 effective in animal model of stroke

Jan. 28, 1998

Anti-TNF strategy in MS treatment should be reconsidered

Jan. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...